Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2025, quý kết thúc ngày Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Zivo Bioscience's enterprise value was $26.01M on Oct 19, 2026, against $53.43M a year earlier. Over the last 5 years it ranged from -$260.91K to $214.95M, with a median of $60.50M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $26.01M | -21.9% |
| 2025 | Dec 31, 2025 | $33.30M | -55.5% |
| 2024 | Dec 31, 2024 | $74.88M | +11837.2% |
| 2023 | Dec 29, 2023 | $627.32K | -99.5% |
| 2022 | Dec 30, 2022 | $138.17M | -8.7% |
| 2021 | Dec 31, 2021 | $151.36M | -58.7% |
| 2020 | Dec 31, 2020 | $366.18M | +0.4% |
| 2019 | Dec 31, 2019 | $364.89M | +178.1% |
| 2018 | Dec 31, 2018 | $131.20M | +75.3% |
| 2017 | Dec 29, 2017 | $74.86M | -8.0% |
| 2016 | Dec 30, 2016 | $81.38M | +21.0% |
| 2015 | Dec 31, 2015 | $67.27M | +9.2% |
| 2014 | Dec 31, 2014 | $61.61M | -76.8% |
| 2013 | Dec 31, 2013 | $265.58M | +125.9% |
| 2012 | Dec 31, 2012 | $117.58M | -19.8% |
| 2011 | Dec 30, 2011 | $146.58M | – |
See a number that looks wrong?